Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease

Abstract

The present study is the first to demonstrate that both higher and lower serum FGF21 levels were associated with increased risks for all-cause and CVD mortality, independent of traditional CVD risk factors.